InvestorsHub Logo
Followers 71
Posts 7941
Boards Moderated 0
Alias Born 01/29/2015

Re: shell3 post# 25317

Tuesday, 05/14/2019 3:39:22 PM

Tuesday, May 14, 2019 3:39:22 PM

Post# of 27550
Once we get past all the numbers jargon...of course Algernon is not done. Simply read/follow all the news releases. The difference now between BLO and AGN is time - the end game. Clinical Trials @ AGN are imminent. If successful there's likely a buyout in the offering, or partner$hip($) deal with big pharma. No more twisting stories coming from management from one year to the next. I simply have no idea where BLO is headed now. What I do know is it's not commercialization/monetization anytime soon...if ever.

Of note: Algernon is planning to launch minimum of 2 simultaneous Phase IIa clinical trials. A successful Phase IIa clinical trial will be measurable in terms of months not years. AGN shareholders are looong overdue for a much deserved win. The days of BTH/AGN getting wagged around like the tail end of BLO are assuredly coming to an end my friends.

/////AMG
Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Recent BLOZF News